CPP Members! There will be a new Pfizer contract in place effective July 1, 2025 that offers CPP members an additional discount on Trumenba® (MenB) and Penbraya™ (MenABCWY) purchases. In October 2024, the ACIP approved Penbraya™ as an option for patients who are recommended to receive both the MenACWY and the MenB shot at the same visit.
Updated pricing sheets can be obtained by contacting the CPP office at cpp@nationwidechildrens.org.
If you are considering incorporating this vaccine into your schedule, we recommend reaching out to your major payers to ensure adequate payment is in place for CPT code 90623. If you would like help with an analysis to forecast the financial impact of this schedule change, please reach out to CPP to discuss details and access helpful financial modeling tools.
